Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer

NCT00040170 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
50
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Transgene

Collaborators